You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
NAD Metabolism in Cancer Therapeutics
|
|---|---|
| Published in |
Frontiers in oncology, December 2018
|
| DOI | 10.3389/fonc.2018.00622 |
| Pubmed ID | |
| Authors |
Keisuke Yaku, Keisuke Okabe, Keisuke Hikosaka, Takashi Nakagawa |
X Demographics
The data shown below were collected from the profiles of 34 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 5 | 15% |
| United States | 2 | 6% |
| Japan | 2 | 6% |
| Germany | 1 | 3% |
| Chile | 1 | 3% |
| Venezuela, Bolivarian Republic of | 1 | 3% |
| Cambodia | 1 | 3% |
| Canada | 1 | 3% |
| New Zealand | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 19 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 30 | 88% |
| Scientists | 3 | 9% |
| Practitioners (doctors, other healthcare professionals) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 215 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 215 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 33 | 15% |
| Researcher | 26 | 12% |
| Student > Master | 19 | 9% |
| Student > Bachelor | 16 | 7% |
| Student > Doctoral Student | 11 | 5% |
| Other | 31 | 14% |
| Unknown | 79 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 56 | 26% |
| Medicine and Dentistry | 16 | 7% |
| Agricultural and Biological Sciences | 11 | 5% |
| Chemistry | 9 | 4% |
| Immunology and Microbiology | 8 | 4% |
| Other | 34 | 16% |
| Unknown | 81 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2023.
All research outputs
#857,492
of 25,483,400 outputs
Outputs from Frontiers in oncology
#136
of 22,581 outputs
Outputs of similar age
#19,300
of 445,506 outputs
Outputs of similar age from Frontiers in oncology
#3
of 228 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,581 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,506 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 228 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.